journal article·2026-07

Bioprinted dECM particles-laden microgels enhance the mesenchymal stromal cell paracrine effect for myocardial infarction treatment

Shiqin Peng, Ying Hao, Bo Li, Jingruo Chen, Hao Zhou, Tailuo Liu, Dingyi Zhang, Lifan Xu, Qiyue Liao, Hanif Ullah, Yuwen Chen, Mao Chen

Acta Biomaterialia· Volume 218
Publisher page

Abstract

Despite guideline-directed reperfusion and pharmacological therapies, myocardial infarction (MI) continues to pose substantial clinical challenges, with high incidence and mortality rates. Mesenchymal stromal cell (MSC) transplantation represents a promising therapeutic strategy, yet its efficacy remains limited by poor survival and unstable paracrine function of transplanted cells within the hostile infarct microenvironment. Here, we developed an integrated microcarrier system via digital light processing, which encapsulates MSCs within microgels functionalized with cardiac-derived decellularized extracellular matrix (dECM) particles (termed MSCs@dECMMG). By leveraging the native biochemical composition and structural cues of cardiac dECM, this bioinspired microcarrier was designed not only to enhance MSC viability but also to actively modulate their secretory activity. Conditioned medium from MSCs@dECMMG promoted angiogenic responses in human umbilical vein endothelial cells and attenuated oxidative stress‑induced apoptosis in H9c2 cells. In the rat MI model, local implantation of MSCs@dECMMG markedly improved the left ventricular ejection fraction from 32.03% to 60.77%, reduced the fibrotic area by 17.44%, and increased the left ventricular wall thickness by 2.6-fold. Collectively, this study demonstrates that a dECM‑integrated microgel can serve as a bioactive carrier that directs MSC secretory signaling, offering a novel strategy to advance cell‑based therapy for MI. STATEMENT OF SIGNIFICANCE: Low survival and unstable paracrine effects of transplanted MSCs in the hostile infarct microenvironment remain a major clinical challenge. Addressing how to specifically enhance MSC paracrine function is critical for effective cardiac repair. Here, we present a precision-engineered microcarrier system that integrates mechanically ground cardiac dECM particles into DLP-bioprinted microgels to deliver MSCs. Unlike prior studies focusing on proliferation or differentiation behaviors, we further uncovered and harnessed cardiac dECM to potentiate MSC paracrine signaling, markedly improving myocardial repair following MI. This introduces a new dimension to dECM application-from guiding differentiation to paracrine enhancement-while providing a translational-ready platform with scalability and controllability for future cell-based therapies.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. 2025 Heart disease and stroke statistics: a report of US and global data from the American Heart Association10.1161/CIR.0000000000001303 ↗
2. Advanced cardiac patches for the treatment of myocardial infarction10.1161/CIRCULATIONAHA.123.067097 ↗
3. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction10.1038/s41467-019-11091-2 ↗
4. The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy10.1016/j.arr.2023.101980 ↗
5. Donor heart preservation with hypoxic-conditioned medium-derived from bone marrow mesenchymal stem cells improves cardiac function in a heart transplantation model10.1186/s13287-020-02114-7 ↗
6. Extruded mesenchymal stem cell nanovesicles are equally potent to natural extracellular vesicles in cardiac repair10.1021/acsami.1c08044 ↗
7. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization10.1093/cvr/cvz040 ↗
8. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E210.1186/s13287-020-01633-7 ↗
9. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing10.1152/physrev.00009.2023 ↗
10. Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials10.1186/s13287-021-02667-1 ↗
11. A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction10.1016/j.ijcard.2013.04.112 ↗
12. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial10.1186/s13287-020-02096-6 ↗
13. Decellularized extracellular matrix-based bioinks for engineering tissue- and organ-specific microenvironments10.1021/acs.chemrev.9b00808 ↗
14. Bioactive scaffolds for tissue engineering: a review of decellularized extracellular matrix applications and innovations10.1002/EXP.20230078 ↗
15. Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro10.1016/j.actbio.2013.08.037 ↗
16. Organ-derived decellularized extracellular matrix: a game changer for Bioink manufacturing?10.1016/j.tibtech.2018.03.003 ↗
17. Decellularized extracellular matrix: new promising and challenging biomaterials for regenerative medicine10.1016/j.biomaterials.2022.121786 ↗
18. Decellularized extracellular matrix biomaterials for regenerative therapies: advances, challenges and clinical prospects
19. Tissue matrix arrays for high-throughput screening and systems analysis of cell function10.1038/nmeth.3619 ↗
20. Directed differential behaviors of multipotent adult stem cells from decellularized tissue/organ extracellular matrix bioinks10.1016/j.biomaterials.2019.119496 ↗
21. Polymeric hydrogels as mesenchymal stem cell secretome delivery system in biomedical applications10.3390/polym14061218 ↗
22. High-throughput bioprinting of geometrically-controlled pre-vascularized injectable microgels for accelerated tissue regeneration
23. Hydrogel microparticles for biomedical applications10.1038/s41578-019-0148-6 ↗
24. Noninvasive in vivo 3D bioprinting10.1126/sciadv.aba7406 ↗
25. DLP printed hDPSC-loaded GelMA microsphere regenerates dental pulp and repairs spinal cord10.1016/j.biomaterials.2023.122137 ↗
26. Extracellular matrix particle-glycosaminoglycan composite hydrogels for regenerative medicine applications10.1002/jbm.a.36218 ↗
27. Precise tuning of facile one-pot gelatin methacryloyl (GelMA) synthesis10.1038/srep31036 ↗
28. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction10.1038/nm1391 ↗
29. Ion cocktail therapy for myocardial infarction by synergistic regulation of both structural and electrical remodeling
30. Local delivery of stem cell spheroids with protein/polyphenol self-assembling armor to improve myocardial infarction treatment via immunoprotection and immunoregulation10.1016/j.biomaterials.2024.122526 ↗
31. Integrated micro/nanoengineered functional biomaterials for cell mechanics and mechanobiology: a materials perspective10.1002/adma.201304431 ↗
32. A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy10.1016/j.cej.2022.135088 ↗
33. Promotion of quiescence and maintenance of function of mesenchymal stem cells on substrates with surface potential10.1016/j.bioelechem.2025.108920 ↗
34. Comparative metabolomic and transcriptomic analysis of 2D and 3D mesenchymal stem cell cultures for improved therapeutic applications
35. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease10.1016/j.stem.2012.02.005 ↗
36. Chemotactic NO/H(2)S nanomotors realizing cardiac targeting of G-CSF against myocardial ischemia-reperfusion injury10.1021/acsnano.3c02781 ↗
37. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype
38. Interleukin-6 mediates post-infarct repair by cardiac explant-derived stem cells10.7150/thno.19435 ↗
39. Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome10.1038/s41420-022-01235-7 ↗
40. Recent advances in the application of injectable hydrogels for myocardial infarction10.53388/BMEC2025025 ↗
41. Cardioprotective C-kit⁺ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice - in-vivo assessment with fluorescence molecular imaging10.7150/thno.5938 ↗
42. Macrophage-targeted cerium-tannic acid metal-polyphenol framework nanoenzyme promotes in situ heart valves regeneration through adaptive immunomodulation
43. A matrix-metalloproteinase-responsive hydrogel system for modulating the immune microenvironment in myocardial infarction10.1002/adma.202209041 ↗
44. An injectable conductive hydrogel with dual responsive release of rosmarinic acid improves cardiac function and promotes repair after myocardial infarction
45. Enhancing immunomodulatory function of mesenchymal stromal cells by hydrogel encapsulation10.3390/cells13030210 ↗
46. A promising strategy for repairing tissue damage: mitochondria transfer from mesenchymal stem cells10.53388/BMEC2023018 ↗
47. Cell-cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias?10.1016/j.lfs.2011.12.009 ↗
48. The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury10.1016/j.intimp.2023.110714 ↗